A detailed history of Bigelow Investment Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Bigelow Investment Advisors, LLC holds 1,948 shares of ABT stock, worth $225,773. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,948
Previous 1,973 1.27%
Holding current value
$225,773
Previous $205,000 8.29%
% of portfolio
0.1%
Previous 0.1%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$100.07 - $118.13 $2,501 - $2,953
-25 Reduced 1.27%
1,948 $222,000
Q1 2024

May 08, 2024

SELL
$109.52 - $120.96 $2,299 - $2,540
-21 Reduced 1.05%
1,973 $224,000
Q4 2023

Jan 31, 2024

BUY
$90.19 - $110.4 $179,838 - $220,137
1,994 New
1,994 $219,000
Q2 2023

Jul 25, 2023

SELL
$100.78 - $112.29 $21,365 - $23,805
-212 Reduced 9.1%
2,118 $230,000
Q1 2023

May 09, 2023

SELL
$96.86 - $114.01 $79,618 - $93,716
-822 Reduced 26.08%
2,330 $235,000
Q4 2022

Jan 26, 2023

SELL
$95.06 - $111.52 $11,882 - $13,940
-125 Reduced 3.81%
3,152 $0
Q3 2022

Nov 10, 2022

SELL
$96.76 - $112.03 $38,994 - $45,148
-403 Reduced 10.95%
3,277 $317,000
Q2 2022

Jul 18, 2022

SELL
$102.07 - $123.37 $39,092 - $47,250
-383 Reduced 9.43%
3,680 $400,000
Q1 2022

Apr 29, 2022

SELL
$114.02 - $139.04 $18,699 - $22,802
-164 Reduced 3.88%
4,063 $481,000
Q4 2021

Feb 11, 2022

BUY
$115.53 - $141.46 $20,333 - $24,896
176 Added 4.34%
4,227 $595,000
Q3 2021

Nov 04, 2021

SELL
$116.66 - $129.06 $25,081 - $27,747
-215 Reduced 5.04%
4,051 $479,000
Q1 2021

May 06, 2021

SELL
$108.84 - $128.23 $4,571 - $5,385
-42 Reduced 0.97%
4,266 $511,000
Q4 2020

Feb 12, 2021

SELL
$105.0 - $114.42 $5,250 - $5,721
-50 Reduced 1.15%
4,308 $472,000
Q3 2020

Nov 10, 2020

BUY
$91.64 - $111.29 $3,390 - $4,117
37 Added 0.86%
4,358 $474,000
Q2 2020

Aug 11, 2020

SELL
$76.57 - $98.0 $35,911 - $45,962
-469 Reduced 9.79%
4,321 $395,000
Q1 2020

May 05, 2020

SELL
$62.82 - $91.86 $10,993 - $16,075
-175 Reduced 3.52%
4,790 $378,000
Q4 2019

Jan 31, 2020

SELL
$78.51 - $87.4 $13,582 - $15,120
-173 Reduced 3.37%
4,965 $431,000
Q2 2019

Jul 17, 2019

SELL
$72.88 - $85.0 $14,576 - $17,000
-200 Reduced 3.75%
5,138 $432,000
Q1 2019

Apr 25, 2019

SELL
$66.22 - $80.06 $33,110 - $40,030
-500 Reduced 8.56%
5,338 $427,000
Q4 2018

Jan 29, 2019

SELL
$65.56 - $74.27 $6,556 - $7,427
-100 Reduced 1.68%
5,838 $422,000
Q3 2018

Nov 05, 2018

SELL
$60.81 - $73.36 $33,141 - $39,981
-545 Reduced 8.41%
5,938 $436,000
Q2 2018

Jul 19, 2018

SELL
$57.57 - $63.54 $32,814 - $36,217
-570 Reduced 8.08%
6,483 $395,000
Q1 2018

Apr 19, 2018

BUY
$56.27 - $63.62 $135,498 - $153,196
2,408 Added 51.84%
7,053 $423,000
Q4 2017

Feb 09, 2018

BUY
$53.68 - $57.47 $249,343 - $266,948
4,645
4,645 $265,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Bigelow Investment Advisors, LLC Portfolio

Follow Bigelow Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bigelow Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bigelow Investment Advisors, LLC with notifications on news.